C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 311/74 (2006.01) A61K 31/352 (2006.01) A61P 3/04 (2006.01)
Patent
CA 2647981
19-nor-vitamin D analogs having an additional heterocyclic ring connecting the 3.beta.-oxygen and carbon-2 or the 1.alpha.-oxygen and carbon-2 of the A-ring of the analog, and pharmaceutical uses therefore, are described. These compounds exhibit significant activity in mobilization of bone, making them therapeutic agents for the treatment or prophylaxis of osteoporosis, osteomalacia, osteopenia, renal osteodystrophy and hypoparathyroidism.
L'invention concerne des analogues de la 19-nor-vitamine D, qui présentent un noyau hétérocyclique supplémentaire reliant le 3.beta.-oxygène et le carbone-2 ou le l.alpha.-oxygène et le carbone-2 du noyau A de l'analogue; et leurs utilisations pharmaceutiques. Ces composés présentent une activité considérable de mobilisation de l'os, ce qui en fait des agents thérapeutiques destinés au traitement ou à la prophylaxie de l'ostéoporose, l'ostéomalacie, l'ostéopénie, l'ostéodystrophie rénale et l'hypoparathyroïdie.
Clagett-Dame Margaret
Deluca Hector F.
Glebocka Agnieszka
Plum Lori A.
Sicinski Rafal R.
Borden Ladner Gervais Llp
Wisconsin Alumni Research Foundation
LandOfFree
19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1436927